Sep 2, 2022, 15:13 PM by

Sep 2, 2022, 15:13 PM by

Sep 2, 2022, 15:12 PM by

Clearwater announced today that its planned merger with CynergisTek has been completed, bringing together two market leaders who are joining forces to serve the cybersecurity, privacy, and compliance needs of healthcare organizations, as well as those in other highly regulated industries. As a result of the transaction, CynergisTek is now a privately owned company and will operate as a subsidiary of Clearwater, aside Clearwater’s recently acquired TECH LOCK Division. Common mission, values, and customer focus among all three companies provide a strong foundation to create a clear market leader in healthcare cybersecurity and compliance.

Sep 1, 2022, 10:42 AM by

SEKISUI announces their newest bioanalytical method, PALSAR, which is a proprietary hybridization method for the measurement of oligonucleotides, ADCs and other intermediate molecules.

Sep 1, 2022, 01:00 AM by User Not Found

Bio-IT World | Investigators at Cedars-Sinai and the National Institute of Allergy and Infectious Diseases have used high throughput sequencing and human serum to characterize the reactivities of immunoglobulin G to microorganisms in the gastrointestinal tract that crossed the intestinal mucosal barrier. The novel technique for identifying translocating gut bacteria sheds light on the interactions between the host and its gut microbiota.

Aug 31, 2022, 09:30 AM by

Aug 31, 2022, 09:29 AM by

Curebase, a company committed to democratizing access to clinical studies, has named veteran digital infrastructure executive Matt Lanier as vice president of engineering.

Aug 31, 2022, 09:28 AM by

Cotiviti and health plan executives will discuss how to intelligently drive member interventions and achieve premium accuracy

Aug 31, 2022, 09:27 AM by

Cloud software platform PubHive Navigator earns ‘Best Integrated Pharmacovigilance Literature & Aggregate Safety Reporting Solutions’ award from Global Health & Pharma Magazine

Aug 31, 2022, 09:27 AM by

Aug 31, 2022, 01:00 AM by User Not Found

Bio-IT World | A new gene-editing technology center opens in Pittsburgh; phage-derived gene delivery vehicles create central nervous system genetic medicines; a new CAR-T cell therapy aims to help people with HIV; and more.

Aug 30, 2022, 11:03 AM by

Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, lengthy turnaround times can limit the clinical utility of these results. To meet the need for rapid genomic insights, Thermo Fisher Scientific today launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.

Aug 30, 2022, 11:03 AM by

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor

Aug 30, 2022, 11:02 AM by

ZeOmega®, the leading population health management organization, today announced that it is featured in the KLAS Research CMS Payer Interoperability 2022 Vendor Guide. The report lists ZeOmega as one of the top performing companies whose solutions help payers comply with regulations for secure data exchange.

Aug 30, 2022, 10:59 AM by

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.

Aug 30, 2022, 10:58 AM by

MMS Holdings, a data-focused contract research organization, announced the appointment of Kelly J. Hill to Chief Strategy Officer. This announcement comes as the company is accelerating in growth after its partnership with a private equity firm.

Aug 30, 2022, 08:00 AM by User Not Found

Bio-IT World | Lawmakers and animal welfare groups are calling for the FDA to abolish animal testing requirements for products under its jurisdiction.

Aug 30, 2022, 01:00 AM by User Not Found

Bio-IT World | AI-enabled drug discovery and sustainable development, a novel antitumor glioma platform, virtual reality operating theaters, and more.

Aug 26, 2022, 10:06 AM by

Aug 26, 2022, 10:05 AM by